PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
September 20, 2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Original source
here.
Recent news
February 4, 2025
World Cancer Day: trends in cancer therapeutics to look forward to in 2025
Read more
January 23, 2025
3 Israeli companies win 2025 BIG Innovation Awards
Read more
January 23, 2025
Health IT Business News – January 23, 2025
Read more
January 17, 2025
OncoHost wins 2025 BIG Innovation Award for healthcare
Read more
January 16, 2025
OncoHost Wins 2025 BIG Innovation Award for Healthcare
Read more
January 15, 2025
Proteomics Predictor for Immunotherapy Benefit
Read more
Read all news
